Haibing Wang
Zhejiang Chinese Medical University(CN)University of Shanghai for Science and Technology(CN)Harbin Medical University(CN)Northeast Agricultural University(CN)Anhui Medical University(CN)Third Affiliated Hospital of Harbin Medical University(CN)Second Hospital of Anhui Medical University(CN)Second Affiliated Hospital of Anhui Medical University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Bioactive Compounds and Antitumor Agents, Lipid metabolism and disorders, Renal Diseases and Glomerulopathies, Inflammasome and immune disorders
Most-Cited Works
- → Caspase 3/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity(2021)206 cited
- → Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models(2016)79 cited
- → Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway(2014)55 cited
- → Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E(2012)40 cited
- → β,β-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis through ERK Pathway in Human Gastric Cancer SGC-7901 Cells(2012)28 cited
- → Calcineurin inhibitors ameliorate PAN‐induced podocyte injury through the NFAT–Angptl4 pathway(2020)